SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
202.60    2.60 (1.30%)
Bid:
203.20
Ask:
203.60
Spread: 0.40 (0.197%)
Market Cap: £3.96b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Stabilisation Notice

26 Oct 2016 07:00

RNS Number : 4526N
ConvaTec Group PLC
26 October 2016
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

ConvaTec Group plc (the "Company")

Stabilisation Notice

26 October 2016

Goldman Sachs International (contact: Craig Loftus; telephone: +44 (0)20 7774 1000) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with the relevant provisions of the Market Abuse Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) 2016/1052.

The securities:

Issuer:

ConvaTec Group plc

Securities:

Ordinary shares ("ORDs") of the Issuer (ISIN: GB00BD3VFW73)

Offering size:

659,734,996

Offer price:

225p

Stabilisation:

Stabilising Manager:

Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB

Stabilisation period expected to start on:

26 October 2016 at 8:00am

Stabilisation period expected to end no later than:

25 November 2016 (close of business)

Maximum size of over-allotment facility:

15% of global offer

Trading venue where stabilisation may be undertaken:

London Stock Exchange

Over-allotment Option:

Terms:

The Over-allotment Shareholders have granted Goldman Sachs International, in its capacity as Stabilising Manager and for the account of the underwriters, the option to acquire up to an additional 98,960,249 ORDs at the Offer price.

Duration:

This option may be executed at any time during the stabilisation period.

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States. The distribution of this announcement in other jurisdictions may be restricted by law, and persons whose possession this announcement comes into should inform themselves about, and observe, such restrictions.

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAPGGPAUUPQUUQ
Date   Source Headline
18th Sep 20197:00 amRNSAcquisition
12th Sep 20194:00 pmRNSScrip Dividend - Calculation Price
19th Aug 20197:00 amRNSJohn McAdam appointed Chairman of ConvaTec
8th Aug 20194:30 pmRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSConvaTec Group Plc First Half Results 2019
25th Jun 20197:00 amRNSBOARD CHANGE
20th Jun 20192:20 pmRNSDirector Declaration
31st May 20193:30 pmRNSTotal Voting Rights
17th May 201912:30 pmRNSDirector/PDMR Shareholding
9th May 20194:30 pmRNSResult of AGM
3rd May 20197:00 amRNSConvaTec Q1 Trading Update
29th Apr 20192:30 pmRNSScrip Dividend - total issued shares
18th Apr 20192:47 pmRNSHolding(s) in Company
11th Apr 20192:15 pmRNSScrip Dividend - calculation price
11th Apr 201910:00 amRNSHolding(s) in Company
10th Apr 201910:30 amRNSHolding(s) in Company
3rd Apr 20198:45 amRNSNotice of AGM
29th Mar 201911:52 amRNSDirector/PDMR Shareholding
29th Mar 201911:21 amRNSHolding(s) in Company
25th Mar 20197:01 amRNSBoard changes
25th Mar 20197:00 amRNSAppointment of Chief Executive Officer
6th Mar 20191:00 pmRNSDirector/PDMR Shareholding
27th Feb 201912:40 pmRNS2018 Annual Report & Accounts
14th Feb 20197:04 amRNSFourth Quarter and Annual Results 2018
8th Jan 20192:00 pmRNSHolding(s) in Company
2nd Jan 201910:30 amRNSHolding(s) in Company
18th Dec 20182:15 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20186:42 pmRNSDirector/PDMR Shareholding
22nd Oct 20182:00 pmRNSHolding(s) in Company
19th Oct 201811:30 amRNSHolding(s) in Company
16th Oct 20185:15 pmRNSDirector/PDMR Shareholding
16th Oct 20181:15 pmRNSDirector/PDMR Shareholding
16th Oct 201810:15 amRNSDirector/PDMR Shareholding
15th Oct 20182:30 pmRNSDirector/PDMR Shareholding
15th Oct 20187:00 amRNSRetirement of Chief Executive Officer
15th Oct 20187:00 amRNS3rd Quarter Results
28th Sep 201811:30 amRNSScrip Dividend - total issued shares
13th Sep 20184:00 pmRNSScrip Dividend - calculation price
13th Sep 201810:10 amRNSHolding(s) in Company
13th Sep 201810:00 amRNSHolding(s) in Company
7th Aug 20189:23 amRNSHolding(s) in Company
6th Aug 20182:36 pmRNSDirector/PDMR Shareholding
3rd Aug 201811:55 amRNSDirector/PDMR Shareholding
3rd Aug 201811:25 amRNSDirector/PDMR Shareholding
2nd Aug 20187:00 amRNSConvaTec Group Plc First Half Results 2018
27th Jul 201812:35 pmRNSHolding(s) in Company
24th Jul 20187:00 amRNSUS FDA 510(k) Clearance for AQUACELT Ag Advantage
23rd Jul 20183:27 pmRNSHolding(s) in Company
23rd Jul 20189:39 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.